Clinical Trial Update: Uterotonics Using to Reduce Bleeding at Cesarean Section [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating uterotonics to reduce bleeding during cesarean section for postpartum haemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Haemorrhage

Snippet

Sponsor: Assiut University | Conditions: Postpartum Haemorrhage | Phase 2 | Status: COMPLETED